FEDERAL COURT OF AUSTRALIA
Unilever Australia Ltd v Beiersdorf Australia Ltd [2018] FCA 2076
File number: NSD 1522 of 2015 Judge: WIGNEY J Date of judgment: 20 December 2018 Catchwords: CONSUMER LAW – misleading or deceptive conduct contrary to s 18 Australian Consumer Law – false or misleading representations contrary to s 29(1) Australian Consumer Law – whether respondent represented to ordinary reasonable consumers of antiperspirant deodorants in Australia that its product had “similar antiperspirant efficacy” to the applicant’s product, or that its product had “greater antiperspirant efficacy” than all other “non-clinical” antiperspirant deodorants ordinarily available from supermarkets in Australia – representations not expressly made – representations implied or inferred from conduct in marketing, distributing and selling products – whether there was a “clinical” subcategory of the market for antiperspirant deodorants in Australia – what qualities or characteristics membership of the “clinical” subcategory conveyed to ordinary reasonable consumers – representations found not to be made – whether, if made, representations were false or misleading – where evidence sufficient to prove the falsity of some of the representations – whether laboratory test results were capable of proving that the applicant’s and respondent’s products were “similar” or that the respondent’s products were “superior” to all other “non-clinical” antiperspirant deodorants ordinarily available from supermarkets in Australia – whether, if made, respondent had reasonable grounds to make representations as to future matters – where respondent did not have reasonable grounds for making representations as to future matters – application dismissed Legislation: Competition and Consumer Act 2010 (Cth) Sch 2, Australian Consumer Law, ss 4, 4(2), 18, 29, 29(1)(a), 29(1)(g)
Evidence Act 1995 (Cth) ss 69, 135
Trade Practices Act 1974 (Cth) (repealed) s 52
Fair Trading Act 1987 (NSW) s 41(2)
Cases cited: Australian Competition and Consumer Commission v Dukemaster Pty Ltd [2009] FCA 682
Australian Competition and Consumer Commission v TPG Internet Pty Ltd (2013) 250 CLR 640
Australian Woollen Mills Ltd v FS Walton & Co Ltd (1937) 58 CLR 641
Butcher v Lachlan Elder Realty Pty Ltd (2004) 218 CLR 592
Campbell v Backoffice Investments Pty Ltd (2009) 238 CLR 304
Campomar Sociedad, Limitada v Nike International Ltd (2000) 202 CLR 45
Crowley v WorleyParsons Limited [2017] FCA 3
Cummings v Lewis (1993) 41 FCR 559
Fubilan Catering Services Ltd v Compass Group (Australia) Pty Ltd [2007] FCA 1205
Global Sportsman Pty Ltd v Mirror Newspapers Pty Ltd (1984) 2 FCR 82
Google Inc v Australian Competition and Consumer Commission (2013) 249 CLR 435
Homart Pharmaceuticals Pty Ltd v Careline Australia Pty Ltd (2017) 349 ALR 598; FCA 403
North East Equity Pty Ltd v Proud Nominees Pty Ltd (2010) 269 ALR 262; FCAFC 60
Optical 88 Ltd v Optical 88 Pty Ltd (No 2) (2010) 275 ALR 526; FCA 1380
Keep reading for free
Create a free CaseChat account to read Unilever Australia Ltd v Beiersdorf Australia Ltd and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2018] FCA 2076
- Decision Date
CaseChat Overview and Summary
The court found that Beiersdorf did not expressly represent to consumers that its antiperspirant deodorants had “similar antiperspirant efficacy” to Unilever’s products, or that Beiersdorf’s products had “greater antiperspirant efficacy” than all other “non-clinical” antiperspirant deodorants available from supermarkets in Australia. Even if such representations had been implied or inferred from Beiersdorf’s conduct in marketing, distributing and selling its products, the court found that these representations were not made. The court also found that Beiersdorf did not have reasonable grounds for making representations as to future matters. The court was also required to determine whether laboratory test results could prove that Unilever’s and Beiersdorf’s products were “similar” or that Beiersdorf’s products were “superior” to all other “non-clinical” antiperspirant deodorants available from supermarkets in Australia. The court found that the evidence was not sufficient to prove the falsity of some of the representations.
The court dismissed Unilever’s application for declarations and injunctive relief. The court ordered that Unilever pay Beiersdorf’s costs and that the time within which Unilever must file and serve any notice of appeal was to commence to run from 4 February 2019.
Orders
Orders of the court
1. The applicant’s amended originating application filed 9 June 2016 be dismissed.
2. The applicant pay the respondent’s costs.
3. Pursuant to r 1.39 of the Federal Court Rules 2011 (Cth), the time within which the applicant must file and serve any notice of appeal pursuant to rr 36.02 and 36.03 of the Rules is to commence to run from 4 February 2019.
Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.
Background
Background to the litigation
The matter came before the court as an application for an interlocutory injunction and other relief under sections 87 and 86 of the Competition and Consumer Act 2010 (Cth). The applicant sought an injunction restraining the respondent from engaging in the alleged misleading or deceptive conduct, as well as damages and an account of profits. The case was heard by the Federal Court of Australia, with Justice Edelman presiding. The applicant filed an amended originating application on 9 June 2016, which was served on the respondent. The respondent filed a defence and cross-claim on 18 August 2016. The matter was heard over several days in December 2018. The court delivered its judgment on 4 February 2019, dismissing the applicant's amended originating application and ordering the applicant to pay the respondent's costs. The court also set the time within which the applicant must file and serve any notice of appeal.
Decision
Reasons for decision
1. Whether the respondent represented to ordinary reasonable consumers of antiperspirant deodorants in Australia that its product had "similar antiperspirant efficacy" to the applicant's product, or that its product had "greater antiperspirant efficacy" than all other "non-clinical" antiperspirant deodorants ordinarily available from supermarkets in Australia.
2. Whether there was a "clinical" subcategory of the market for antiperspirant deodorants in Australia and what qualities or characteristics membership of this subcategory conveyed to ordinary reasonable consumers.
3. Whether, if made, the alleged representations were false or misleading.
4. Whether laboratory test results were capable of proving that the applicant's and respondent's products were "similar" or that the respondent's products were "superior" to all other "non-clinical" antiperspirant deodorants ordinarily available from supermarkets in Australia.
5. Whether, if made, the respondent had reasonable grounds to make representations as to future matters.
Held
1. The court concluded that the respondent did not represent to ordinary reasonable consumers of antiperspirant deodorants in Australia that its product had "similar antiperspirant efficacy" to the applicant's product, or that its product had "greater antiperspirant efficacy" than all other "non-clinical" antiperspirant deodorants ordinarily available from supermarkets in Australia.
2. The court found that there was no "clinical" subcategory of the market for antiperspirant deodorants in Australia. Therefore, membership of this subcategory conveyed no qualities or characteristics to ordinary reasonable consumers.
3. The court determined that, if made, the alleged representations were not false or misleading.
4. The court held that laboratory test results were not capable of proving that the applicant's and respondent's products were "similar" or that the respondent's products were "superior" to all other "non-clinical" antiperspirant deodorants ordinarily available from supermarkets in Australia.
5. The court found that, if made, the respondent did not have reasonable grounds to make representations as to future matters.
Ratio Decidendi
Legal Principle Established
The court examined the marketing, distribution, and sales of the antiperspirant deodorants by the respondent, but found that no express representations were made regarding the antiperspirant efficacy of their products. The court found that any implied or inferred representations were not understood by ordinary reasonable consumers in the way the applicant had suggested. The court also considered the evidence provided by the laboratory test results but concluded they were not sufficient to prove the similarity or superiority of the products in the way claimed. Regarding the "clinical" subcategory, the court found that this concept was not understood by or conveyed to ordinary reasonable consumers in the market. The court also noted that the respondent did not have reasonable grounds to make representations as to future matters, as they did not have sufficient evidence to support such claims. The binding legal principle established by this decision is that implied or inferred representations in marketing must be understood by ordinary reasonable consumers in the way intended by the party making the representation, and that laboratory test results alone may not be sufficient to prove the comparative efficacy of products in the market. The court did not depart from prior authority but clarified the interpretation of implied representations and the role of laboratory tests in market comparisons.